A Label-Free, Quantitative Fecal Hemoglobin Detection Platform for Colorectal Cancer Screening
Open Access
- 5 May 2017
- journal article
- research article
- Published by MDPI AG in Biosensors
- Vol. 7 (2), 19
- https://doi.org/10.3390/bios7020019
Abstract
The early detection of colorectal cancer is vital for disease management and patient survival. Fecal hemoglobin detection is a widely-adopted method for screening and early diagnosis. Fecal Immunochemical Test (FIT) is favored over the older generation chemical based Fecal Occult Blood Test (FOBT) as it does not require dietary or drug restrictions, and is specific to human blood from the lower digestive tract. To date, no quantitative FIT platforms are available for use in the point-of-care setting. Here, we report proof of principle data of a novel low cost quantitative fecal immunochemical-based biosensor platform that may be further developed into a point-of-care test in low-resource settings. The label-free prototype has a lower limit of detection (LOD) of 10 µg hemoglobin per gram (Hb/g) of feces, comparable to that of conventional laboratory based quantitative FIT diagnostic systems.Keywords
This publication has 29 references indexed in Scilit:
- Advances in Fecal Occult Blood Tests: The FIT RevolutionDigestive Diseases and Sciences, 2014
- Epidemiological transition of colorectal cancer in developing countries: Environmental factors, molecular pathways, and opportunities for preventionWorld Journal of Gastroenterology, 2014
- Colorectal cancer: Current imaging methods and future perspectives for the diagnosis, staging and therapeutic response evaluationWorld Journal of Gastroenterology, 2013
- Effect of Flexible Sigmoidoscopy-Based Screening on Incidence and Mortality of Colorectal Cancer: A Systematic Review and Meta-Analysis of Randomized Controlled TrialsPLoS Medicine, 2012
- The dimensions of the CRC problemBest Practice & Research Clinical Gastroenterology, 2010
- International Trends in Colorectal Cancer Incidence RatesCancer Epidemiology, Biomarkers & Prevention, 2009
- Mass screening for colorectal cancer is not justified in most developing countriesInternational Journal of Cancer, 2009
- Which fecal occult blood test is best to screen for colorectal cancer?Nature Reviews Gastroenterology & Hepatology, 2009
- Immunochemical testing of individuals positive for guaiac faecal occult blood test in a screening programme for colorectal cancer: an observational studyThe Lancet Oncology, 2006
- Randomised controlled trial of faecal-occult-blood screening for colorectal cancerThe Lancet, 1996